Cobimetinib | 合法藥品大搜索

Cobimetinib, sold under the brand name Cotellic, is a MEK inhibitor developed by Exelixis and Genentech (Roche). It is used in combination with vemurafenib, ... Read More

Cobimetinib is a tyrosine kinase receptor inhibitor that is used in combination with vemurafenib as therapy for selected forms of advanced malignant melanoma. Read More

可泰利Cotellic/cobimetinib (1顆20 毫克) 是高度選擇的MEK1 及MEK2 酪胺酸-蘇胺酸激酶之標靶抑制劑。 #### 2017/01/05 台灣的適應症#### Cotellic 與Zelboraf ... Read More

Cobimetinib is the generic name for the trade name drug Cotellic™. In some cases, health care professionals may use the trade name Cotellic™ when referring ... Read More

Cobimetinib is an antineoplastic agent and selective inhibitor of the mitogen-activated extracellular kinase (MEK) pathway used to treat unresectable or ... Read More

Medscape - Melanoma dosing for (Cotellic) cobimetinib, frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation ... Read More

COTELLIC is a prescription medicine that is used with the medicine ZELBORAF, to treat a type of skin cancer called melanoma: that has spread to other parts of ... Read More

patients with a BRAF V600 mutation-positive melanoma which has metastasised to the brain. The intracranial activity of cobimetinib is currently unknown (see ... Read More

Cotellic (cobimetinib) ... Cotellic is a kinase inhibitor indicated for the treatment of patients with BRAF V600E or BRAF V600K mutation-positive advanced melanoma ... Read More